Supreme Court Appeal
Case Details:
Access prior opinion A-56-18, decided February 17, 2023, in which the Court adopted for criminal and quasi-criminal cases a non-exclusive, multi-factor test for the reliability of expert testimony patterned after the standard established in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993).
Is Drug Recognition Experts (DRE) evidence – which, in this case, included testimony that defendant was under the influence of narcotics while driving – admissible under the standard articulated in Frye v. United States, 293 F. 1013 (D.C. Cir. 1923) ?
Case Dates:
- Certification granted: March 8, 2019
- Posted: March 13, 2019
- Argued: Oct. 8, 2019
- Reargued (past): Jan. 17, 2023
- Decided (past): Feb. 17, 2023
- Reargued: June 1, 2023
- Decided: Nov. 15, 2023
Audio for A-56-18- Part 1 (06/01/23) Argued Videos
Audio for A-56-18- Part 2 (06/01/23) Argued Videos
Audio for A-56-18- Part 1 (01/17/23) Argued Videos
Audio for A-56-18- Part 2 (01/17/23) Argued Videos
Audio for A-56-18- (10/08/19) Argued Videos